Tubular markers are associated with decline in kidney function in proteinuric type 2 diabetic patients.

[1]  H. Parving,et al.  Elevated NT-proBNP and coronary calcium score in relation to coronary artery disease in asymptomatic type 2 diabetic patients with elevated urinary albumin excretion rate. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[2]  Jiang He,et al.  Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. , 2011, JAMA.

[3]  H. Parving,et al.  Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy. , 2011, Kidney international.

[4]  V. Jorgetti,et al.  FGF-23 as a predictor of renal outcome in diabetic nephropathy. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[5]  H. Parving,et al.  Neutrophil Gelatinase‐Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross‐sectional study and the effects of lisinopril , 2010, Diabetic medicine : a journal of the British Diabetic Association.

[6]  L. Schurgers,et al.  The Associations of Fibroblast Growth Factor 23 and Uncarboxylated Matrix Gla Protein With Mortality in Coronary Artery Disease: The Heart and Soul Study , 2010, Annals of Internal Medicine.

[7]  L. Lind,et al.  Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community. , 2009, Atherosclerosis.

[8]  D. Bolignano,et al.  Neutrophil Gelatinase-Associated Lipocalin as an Early Biomarker of Nephropathy in Diabetic Patients , 2009, Kidney and Blood Pressure Research.

[9]  D. Bolignano,et al.  Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[10]  D. Bolignano,et al.  Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[11]  F. Kronenberg,et al.  Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study. , 2007, Journal of the American Society of Nephrology : JASN.

[12]  M. C. V. D. Heuvel,et al.  Tubular kidney injury molecule‐1 (KIM‐1) in human renal disease , 2007, The Journal of pathology.

[13]  K. Nakao,et al.  Neutrophil gelatinase-associated lipocalin as the real-time indicator of active kidney damage. , 2007, Kidney international.

[14]  Joseph V Bonventre,et al.  Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. , 2006, American journal of physiology. Renal physiology.

[15]  M. Sehested,et al.  Neutrophil Gelatinase-Associated Lipocalin Is Up-Regulated in Human Epithelial Cells by IL-1β, but Not by TNF-α 1 , 2003, The Journal of Immunology.

[16]  L. Sechi,et al.  Regression of microalbuminuria in type 1 diabetes. , 2003, The New England journal of medicine.

[17]  M. Cooper,et al.  The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? , 1999, Kidney international.

[18]  G. Crepaldi,et al.  Patterns of renal injury in NIDDM patients with microalbuminuria , 1996, Diabetologia.

[19]  R. Bader,et al.  Structure and function of the kidney in diabetic glomerulosclerosis. Correlations between morphological and functional parameters. , 1980, Pathology, research and practice.

[20]  S. Satchell,et al.  Diabetic nephropathy. , 2012, Clinical medicine.

[21]  L. Kennedy,et al.  Monitoring Kidney Function in Type 2 Diabetic Patients With Incipient and Overt Diabetic NephropathyRossing P, Pedersen O, Rossing K, et al (Steno Diabetes Ctr, Gentofte, Denmark; Univ of Aarhus, Denmark) Diabetes Care 29:1024–1030, 2006§ , 2007 .

[22]  B. Brenner,et al.  Brenner & Rector's the Kidney , 1996 .